OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
48
Results
Show all
Save search
Copy query
Show results for
Unknown
(46)
Proteomics
(2)
Organisms
Alphavirus
(2)
Betaherpesvirinae
(2)
Brassica oleracea var. oleracea
(2)
Cowpox virus
(2)
Coxsackievirus
(2)
Cytomegalovirus
(2)
Dengue virus
(2)
EFO:0001352
(2)
Filoviridae
(2)
Hepatitis B virus
(2)
Human alphaherpesvirus 1
(2)
Human betaherpesvirus 5
(2)
Human immunodeficiency virus
(2)
Human immunodeficiency virus 1
(2)
Human immunodeficiency virus 2
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Lyssavirus rabies
(2)
Monkeypox virus
(2)
Mus musculus
(2)
Nostoc sp. PCC 7120 = FACHB-418
(2)
Oropouche virus
(2)
Orthopoxvirus
(2)
Orthopoxvirus vaccinia
(2)
Rattus
(2)
Staphylococcus aureus
(2)
Tick-borne encephalitis virus
(2)
Viruses
(2)
West Nile virus
(2)
Repository
pride
(2)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Head and neck squamous cell carcinoma cell
(1)
Disease
Acute leukemia
(1)
Breast cancer
(1)
Colon cancer
(1)
Technology Type
Bottom-up proteomics
(2)
Mass Spectrometry
(2)
Data-independent acquisition
(1)
Publication Date
2026
(2)
Release Date
2017
(7)
2021
(5)
2018
(5)
2023
(4)
2024
(3)
2020
(3)
2019
(3)
2013
(3)
2022
(2)
2016
(2)
2015
(2)
2012
(2)
2011
(2)
2025
(1)
2014
(1)
2009
(1)
Lab affiliation
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States
(1)
Laboratory of Cell and Developmental Signaling, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors.
Not available
S-EPMC4606059
|
biostudies-literature
Cite
Cediranib for metastatic alveolar soft part sarcoma.
Not available
S-EPMC3677840
|
biostudies-literature
Cite
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Not available
S-EPMC5455706
|
biostudies-literature
Cite
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.
Not available
S-EPMC5978471
|
biostudies-literature
Cite
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.
Not available
S-EPMC5648176
|
biostudies-literature
Cite
Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal E<sub>max</sub> regressions.
Not available
S-EPMC10719825
|
biostudies-literature
Cite
Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors.
Not available
S-EPMC4490274
|
biostudies-literature
Cite
Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts.
Not available
S-EPMC3594408
|
biostudies-literature
Cite
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Not available
S-EPMC4860030
|
biostudies-literature
Cite
First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile.
Not available
S-EPMC6126370
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
